Signaling through platelet integrin αIIbβ3: Inside-out, outside-in, and sideways

Thrombosis and Haemostasis

Volumn 82, Issue 2, 1999, Pages 318-325

  Shattil, Sanford J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; FIBRINOGEN; FIBRINOGEN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; MEMBRANE RECEPTOR;

CONFERENCE PAPER; LIGAND BINDING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 0032698162     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615849     Document Type: Conference Paper

References (90)

1. Martin P. Wound healing - aiming for perfect skin regeneration. Science. 1997;276:75-81.
2. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation and flow. Cell. 1998;94:657-666.
3. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood. 1998;91:2645-2657.
4. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng DW, Moff S, Farese RV Jr, Tam C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature. 1998;394:690-694.
5. Jin JG, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA. 1998;95:8070-8074.
6. 1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. Blood. 1998;92:152-159.
7. 1. J Biol Chem. 1997;272:27035-27041.
8. Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest. 1989;84:1440-1445.
9. 1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cγ2 in platelets. J Biol Chem. 1996;271:26668-26676.
10. Watson SP, Gibbins J. Collagen receptor signalling in platelets: extending the role of the ITAM. Immunol Today. 1998;19:260-264.
11. Gayle RB III, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, Brasel K, Price V, Drosopoulos JHF, Islam N, Alyonycheva TN, Broekman MJ, Marcus AJ. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest. 1998;101:1851-1859.
12. Nurden P, Savi P, Heilmann E, Bihour C, Herbert J-M, Maffrand J-P, Nurden A. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets: its influence on glycoprotein IIb-IIIa complex function. J Clin Invest. 1995;95:1612-1622.
13. Daniel JL, Dangelmaier C, Jin JG, Ashby B, Smith JB, Kunapuli SP. Molecular basis for ADP-induced platelet activation I: evidence for three distinct ADP receptors on human platelets. J Biol Chem. 1998;273:2024-2029.
14. Jin JG, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation II: the P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem. 1998;273:2030-2034.
15. Kim YB, Jin J, Dangelmaier C, Daniel JL, Kunapuli SP. The P2Y1 receptor plays an essential role in ADP-induced shape change and aggregation in mouse platelets. Blood. 1998;92:27a.
16. Jantzen H-M, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds EE, Conley PB. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb Haemost. 1999;81:111-117.
17. Kunapuli SP, Dangelmaier C, Jin J, Kim YB, Daniel JL, Rao AK. Role of intracellular signaling events in ADP-induced platelet aggregation. Blood. 1998;92:27a.
18. Brass LF, Manning DR, Cichowski K, Abrams CS. Signaling through G proteins in platelets: to the integrins and beyond. Thromb Haemost. 1997;78:581-589.
19. 2. J Clin Invest. 1998;102:1994-2001.
20. q-deficient mice. Nature. 1997;389:183-186.
21. q in a patient with abnormal platelet responses. Proc Natl Acad USA. 1997;94:8750-8755.
22. Lee SB, Rao AK, Lee KH, Yang X, Bae YS, Rhee SG. Decreased expression of phospholipase C-β2 isozyme in human platelets with impaired function. Blood. 1996;88:1684-91.
23. Guinebault C, Payrastre B, Sultan C, Mauco G, Breton M, Levy-Toledano S, Plantavid M, Chap H. Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets. Biochem J. 1993;292:851-856.
24. Moussazadeh M, Haimovich B. Protein kinase C-δ activation and tyrosine phosphorylation in platelets. FEBS Lett. 1998;438:225-230.
25. Rittenhouse SE. Phosphoinositide 3-kinase activation and platelet function. Blood. 1996;88:4401-4414.
26. Malbon CC, Karoor V. G-protein-linked receptors as tyrosine kinase substrates: new paradigms in signal integration. Cell Signal. 1998;10:523-527.
27. 2 adrenergic receptor Src protein kinase complexes. Science. 1999;283:655-661.
28. Jackson SP, Schoenwaelder SM, Yuan YP, Salem HH, Cooray P. Non-receptor protein tyrosine kinases and phosphatases in human platelets. Thromb Haemost. 1996;76:640-650.
29. Raja S, Avraham S, Avraham H. Tyrosine phosphorylation of the novel protein-tyrosine kinase RAFTK during an early phase of platelet activation by an integrin glycoprotein IIb-IIIa-independent mechanism. J Biol Chem. 1997;272:10941-10947.
30. Hamazaki Y, Kojima H, Mano H, Nagata Y, Todokoro K, Abe T, Nagasawa T. Tec is involved in G protein-coupled receptor and integrin-mediated signalings in human blood platelets. Oncogene. 1998;16:2773-2779.
31. Moroi M, Jung SM. Platelet receptors for collagen. Thromb Haemost. 1997;78:439-444.
32. Kehrel B, Wierwille S, Clemetson KJ, Anders O, Steiner M, Knight CG, Famdale RW, Okuma M, Barnes MJ. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood. 1998;91:491-499.
33. Barnes MJ, Knight CG, Farndale RW. The use of collagen-based model peptides to investigate platelet-reactive sequences in collagen. Biopolymers. 1996;40:383-397.
34. 1. Blood. 1997;89:1235-1242.
35. Polgar J, Clemetson JM, Kehrel BE, Wiedemann M, Magnenat EM, Wells TNC, Clemetson KJ. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem. 1997;272:13576-13583.
36. Gibbins JM, Okuma M, Farndale R, Barnes M, Watson SP. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain. FEBS Lett. 1997;413:255-259.
37. Poole A, Gibbins JM, Turner M, van Vugt MJ, van den Winkel JGJ, Saito T, Tybulewicz VLJ, Watson SP. The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 1997;16:2333-2341.
38. Quek LS, Bolen J, Watson SP. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen. Curr Biol. 1998;8:1137-1140.
39. Clements JL, Lee JR, Gross B, Yang B, Olson JD, Sandra A, Watson SP, Lentz SR, Koretzky GA. Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice. J Clin Invest. 1999;103:(in press).
40. Gross BS, Lee JR, Clements JL, Turner M, Tybulewicz VL, Findell PR, Koretzky GA, Watson SP. Tyrosine phosphorylation of SLP-76 is downstream of Syk following stimulation of the collagen receptor in platelets. J Biol Chem. 1999;274:5963-5971.
41. Gibbins JM, Briddon S, Shutes A, van Vugt MJ, van de Winkel JGJ, Saito T, Watson SP. The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor gamma-chain and linker for activator of T cells (LAT) in platelets stimulated by collagen and convulxin. J Biol Chem. 1998;273:34437-34443.
42. Loftus JC, Liddington RC. Cell adhesion in vascular biology: new insights into integrin-ligand interaction. J Clin Invest. 1997;99:2302-2306.
43. Hemler ME. Integrin associated proteins. Curr Opin Cell Biol. 1998;10:578-585.
44. IIb cytoplasmic domain. J Biol Chem. 1997;272:4651-4654.
45. 3 sub-unit. J Cell Biol. 1995;131:807-816.
46. 3. J Biol Chem. 1994;269:18781-18788.
47. 3 integrin cytoplasmic tail. J Cell Biol. 1997;137:1433-1443.
48. Zhang Z, Vuori K, Wang H-G, Reed JC, Ruoshlati E. Integrin activation by R-ras. Cell. 1996;85:61-69.
49. Hughes PE, Renshaw MW, Pfaff M, Forsyth J, Keivens VM, Schwartz MA, Ginsberg MH. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP-kinase pathway. Cell. 1996;88:521-530.
50. Kucik DF, Dustin ML, Miller JM, Brown EJ. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest. 1996;97:2139-2144.
51. 3 function in human B lymphocytes. J Biol Chem. 1998;273:15271-5278.
52. 3 for fibrinogen. Blood. 1998;92:702a.
53. Fox JEB. Platelet activation: new aspects. Haemostasis. 1996;26(Suppl 4):102-131.
54. Hemmings L, Barry ST, Critchley DR. Cell-matrix adhesion: structure and regulation. Biochem Soc Trans. 1995;23:619-626.
55. Reddy KB, Gascard P, Price MG, Negrescu EV, Fox JEB. Identification of an interaction between M-band protein skelemin and β-integrin subunits. J Biol Chem. 1998;273:35039-35047.
56. 3. J Cell Biol. 1998;141:1685-1695.
57. 3. EMBO J. 1997;16:6414-6425.
58. 3. J Biol Chem. 1994;46:28859-28864.
59. Miranti C, Leng L, Maschberger P, Brugge JS, Shattil SJ. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr Biol. 1998;8(24):1289-1299.
60. Hartwig JH, Kung S, Kovacsovics T, Janmey PA, Cantley LC, Stossel TP, Toker A. D3 phosphoinositides and outside-in integrin signaling by glycoprotein IIb-IIIa mediate platelet actin assembly and filopodial extension induced by phorbol 12-myristate 13-acetate. J Biol Chem. 1996;271:32986-32993.
61. 3) in von Willebrand factor-induced signal transduction. J Biol Chem. 1997;272:21847-21854.
62. vav, in platelets. J Biol Chem. 1996;271:7544-7550.
63. Burridge K, Chrzanowska-Wodnicka M, Zhong CL. Focal adhesion assembly. Trends Cell Biol. 1997;7:342-347.
64. Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279:509-514.
65. 3. Blood. 1998;91:4206-4215.
66. 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad USA. 1992;89:10169-10173.
67. 3 complex. J Clin Invest. 1997;100:2393-2403.
68. 3. Thromb Haemost. 1998;80:735-742.
69. Law DA, DeGuzman F, Ministri K, Phillips DR. Demonstration of a role for the β3 cytoplasmic tyrosine residues in platelet function using mice expressing a mutant (Y747F, Y759F) β3. Blood. 1998;92:701a.
70. 3 signaling in platelets. Blood. In press.
71. Witke W, Sharpe AH, Hartwig JH, Azuma T, Stossel TP, Kwiatkowski DJ. Hemostatic, inflammatory and fibroblast responses are blunted in mice lacking gelsolin. Cell. 1995;81:41-51.
72. Ambo H, Kamata T, Handa M, Taki M, Kuwajima M, Kawai Y, Oda A, Murata M, Takada Y, Watanabe K, Ikeda Y. Three novel integrin β3 subunit missense mutations (H280P, C560F, and G579S) in thrombasthenia, including one (H280P) prevalent in Japanese patients. Biochem Biophys Res Commun. 1998;251:763-768.
73. 435 disulfide bind in conformational changes of GP IIb-IIIa: substitution of cysteine 5 with alanine results in the production of a constitutively active GPIIb-IIIa integrin complex. Blood. 1998;92:344a.
74. 3. Blood. In press.
75. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 1996;334:1090-1094.
76. Bray PF. Integrin polymorphisms as risk factors for thrombosis. Thromb Haemost. In press.
77. Lefkovits J, Plow EF, Topol EJ. Mechanisms of disease: platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 1995;332:1553-1559.
78. Coller BS. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest. 1997;99:1467-1471.
79. Phillips DR, Law D, Scarborough RM. Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions. Arch Pathol Lab Med. 1998;122:811-812.
80. Sharis PJ, Cannon CP, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med. 1998;129:394-405.
81. Hechler B, Eckly A, Ohlmann P, Cazenave JP, Gachet C. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol. 1998;103:858-66.
82. Stromblad S, Cheresh DA. Cell adhesion and angiogenesis. Trends Cell Biol. 1996;6:462-468.
83. Ruegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P, Lejeune FJ. Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat Med. 1998;4:408-414.
84. 3 in vascular biology. Thromb Haemost. 1998;80:726-734.
85. 3 integrin-mediated attachment to extracellular matrix in β1 integrin (CD29)-negative B cell lines. Exp Cell Res. 1992;203:443-448.
86. 3 on platelets and lymphocytes binds to the matrix protein osteopontin. J Biol Chem. 1997;272:8137-8140.
87. 3 avidity. J Biol Chem. 1997;272:28757-28761.
88. Sadhu C, Masinovsky B, Staunton DE. Differential regulation of chemoattractant-stimulated β2, β3, and β7 integrin activity. J Immunol. 1998;160:5622-8.
89. 3 on vascular cells controls recognition of prothrombin. J Cell Biol. 1998;143:2081-2092.
90. 3. J Biol Chem. (in press).